Natco Pharma and 2 other stocks in which DIIs have increased their stake in Q4

Synopsis:- Domestic institutional investors increased stakes in select stocks during Q4FY26, with holdings rising from 5.39% to 5.46%, 23.20% to 24.15%, and 1.02% to 2.11%. This steady accumulation reflects improving domestic confidence.

Domestic Institutional Investors (DIIs) are entities like mutual funds, insurance companies, and banks that invest in financial markets within India. They play a crucial role in providing stability during market volatility, often counterbalancing foreign investor flows and reflecting domestic confidence in the economy through consistent and long-term investment strategies.

Natco Pharma Ltd

Natco Pharma Ltd is a leading pharmaceutical company engaged in developing and manufacturing generic medicines and specialty drugs. It has a strong presence in oncology and exports, particularly in regulated markets like the US. The company focuses on niche products, innovation, and complex generics to drive long-term growth. With a market capitalisation of Rs 19,505 crore, the shares closed at Rs 1,089 per share, increased around 1.15 percent as compared to the previous closing price.

In Natco Pharma Ltd, DII holding increased slightly from 5.39% in Dec 2025 to 5.46% in March 2026, indicating a marginal improvement in domestic institutional interest. As of March 2026, promoter holding stood at 49.41%, FIIs at 17.37%, and public shareholding at 27.74%, reflecting a well-diversified ownership structure.

Apar Industries Ltd

Apar Industries Ltd is a diversified manufacturing company engaged in conductors, specialty oils, and cables. It serves sectors like power transmission, automotive, and telecom. With a strong export presence and technological capabilities, the company benefits from growing infrastructure demand and increasing global focus on energy and electrification. With a market capitalisation of Rs 45,158 crore, the shares closed at Rs 11,234 per share, increased around 1.14 percent as compared to the previous closing price.

In Apar Industries Ltd, DII holding increased from 23.20% in Dec 2025 to 24.15% in March 2026, indicating strong domestic institutional confidence. As of March 2026, promoter holding remained steady at 57.77%, FIIs stood at 9.38%, while public shareholding declined to 8.71%, reflecting gradual institutional accumulation.

Chennai Petroleum Corporation Ltd

Chennai Petroleum Corporation Ltd is a public sector refinery engaged in producing petroleum products such as diesel, petrol, and lubricants. A subsidiary of Indian Oil, it plays a key role in South India’s energy supply, benefiting from refining capacity and integration within the broader oil and gas value chain. With a market capitalisation of Rs 14,470 crore, the shares closed at Rs 972 per share, increased around 2.83 percent as compared to the previous closing price.

In Chennai Petroleum Corporation Ltd, DII holding increased from 1.02% in Dec 2025 to 2.11% in March 2026, indicating renewed domestic institutional interest. As of March 2026, promoter holding remained steady at 67.29%, FIIs stood at 12.59%, while public shareholding was around 18%, reflecting a balanced ownership structure.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Natco Pharma and 2 other stocks in which DIIs have increased their stake in Q4 appeared first on Trade Brains.